Cellectar Biosciences Ownership 2024 | Who Owns Cellectar Biosciences Now?

Overview Forecast RevenueFinancials Chart Transcripts

Institutional Ownership

0.00%

Insider Ownership

3.20%

Institutional Holders

1.00

Cellectar Biosciences Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MENDOTA FINANCIAL GROUP, LLC	-	-	-	-5	-100.00%	-	Sep 30, 2023

Cellectar Biosciences's largest institutional shareholder is MENDOTA FINANCIAL GROUP, LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MENDOTA FINANCIAL GROUP, LLC	-	-	-	-5	-100.00%	-	Sep 30, 2023

The largest Cellectar Biosciences shareholder by % of total assets is MENDOTA FINANCIAL GROUP, LLC. The company owns 0.00 shares of Cellectar Biosciences (CLRB), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MENDOTA FINANCIAL GROUP, LLC	-	-	-	-5	-100.00%	-	Sep 30, 2023

As of Sep 30 2023, Cellectar Biosciences's largest institutional buyer is MENDOTA FINANCIAL GROUP, LLC. The company purchased -5.00 stocks of CLRB, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MENDOTA FINANCIAL GROUP, LLC	-	-	-	-5	-100.00%	-	Sep 30, 2023

As of Sep 30 2023, Cellectar Biosciences's biggest institutional seller is MENDOTA FINANCIAL GROUP, LLC. The company sold -5.00 shares of CLRB, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MENDOTA FINANCIAL GROUP, LLC	-	-	-	-5	-100.00%	-	Sep 30, 2023

Cellectar Biosciences's largest sold out institutional shareholder by shares sold is MENDOTA FINANCIAL GROUP, LLC, sold -5.00 shares, valued at -, as of undefined.

Cellectar Biosciences Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD VALLEY FORGE FUNDS	0.01%	3,510	-	-	Dec 31, 2023
VANGUARD INDEX FUNDS	0.00%	1,650,818	-	-	Dec 31, 2023
FIDELITY CONCORD STREET TRUST	0.00%	422,731	-	-	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	46,083	-	-	Dec 31, 2023
VANGUARD INDEX FUNDS	0.00%	586,502	417,405	246.84%	Dec 31, 2023
SCHWAB CAPITAL TRUST	0.00%	22,909	-	-	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	4,608	-	-	Dec 31, 2023
Legg Mason Global Asset Management Trust	0.00%	101,244	-	-	Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	32,146	-	-	Jan 31, 2024
Legg Mason Global Asset Management Trust	0.00%	10,124	-	-	Jan 31, 2024
SUNAMERICA SERIES TRUST	0.00%	2,400	-	-	Jan 31, 2024
Dimensional ETF Trust	0.00%	2,031	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	3,208	-	-	Dec 31, 2023
iSHARES TRUST	0.00%	43,190	-	-	Feb 29, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	2,568	-	-	Dec 31, 2023

Cellectar Biosciences's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 3.51K shares, compromising 0.01% of its total assets.

Cellectar Biosciences Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 23	1	-
31 Mar, 23	1	-
30 Jun, 22	28	-
31 Mar, 22	28	-17.65%
31 Dec, 21	34	-2.86%
30 Sep, 21	35	-14.63%
30 Jun, 21	41	-2.38%
31 Mar, 21	42	13.51%
31 Dec, 20	37	94.74%
30 Sep, 20	19	-9.52%
30 Jun, 20	21	50.00%
31 Mar, 20	14	40.00%
31 Dec, 19	10	-9.09%
30 Sep, 19	11	22.22%
30 Jun, 19	9	12.50%
31 Mar, 19	8	-11.11%
31 Dec, 18	9	-18.18%
30 Sep, 18	11	-

As of 30 Jun 23, 1 institutions are holding Cellectar Biosciences's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 23	5	-
31 Mar, 23	5	-
30 Jun, 22	6,561,180	-3.30%
31 Mar, 22	6,784,960	4.28%
31 Dec, 21	6,506,789	-10.71%
30 Sep, 21	7,287,078	-41.51%
30 Jun, 21	12,459,505	-17.09%
31 Mar, 21	15,027,195	-14.93%
31 Dec, 20	17,664,507	411.64%
30 Sep, 20	3,452,550	20.44%
30 Jun, 20	2,866,552	103.24%
31 Mar, 20	1,410,400	8.70%
31 Dec, 19	1,297,481	-13.85%
30 Sep, 19	1,506,142	-19.87%
30 Jun, 19	1,879,701	661.36%
31 Mar, 19	246,887	-6.03%
31 Dec, 18	262,722	-51.50%
30 Sep, 18	541,706	-

Cellectar Biosciences (CLRB) has 5.00 shares outstanding as of 30 Jun 23, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 23	-	-
31 Mar, 23	-	-
30 Jun, 22	107.38%	0.87%
31 Mar, 22	111.04%	0.81%
31 Dec, 21	117.21%	0.79%
30 Sep, 21	121.72%	0.22%
30 Jun, 21	236.14%	0.24%
31 Mar, 21	312.16%	0.23%
31 Dec, 20	366.95%	2.13%
30 Sep, 20	131.14%	0.30%
30 Jun, 20	207.82%	0.92%
31 Mar, 20	150.21%	0.79%
31 Dec, 19	138.18%	0.54%
30 Sep, 19	160.45%	0.22%
30 Jun, 19	269.94%	10.09%
31 Mar, 19	51.72%	0.66%
31 Dec, 18	88.70%	0.31%
30 Sep, 18	170.09%	-

As of 30 Jun 23, Cellectar Biosciences is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 31 Mar 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 23	-	-100.00%
31 Mar, 23	1	-
30 Jun, 22	9	28.57%
31 Mar, 22	7	-46.15%
31 Dec, 21	13	-23.53%
30 Sep, 21	17	-34.62%
30 Jun, 21	26	-3.70%
31 Mar, 21	27	-10.00%
31 Dec, 20	30	233.33%
30 Sep, 20	9	-30.77%
30 Jun, 20	13	116.67%
31 Mar, 20	6	50.00%
31 Dec, 19	4	-20.00%
30 Sep, 19	5	25.00%
30 Jun, 19	4	300.00%
31 Mar, 19	1	-75.00%
31 Dec, 18	4	-63.64%
30 Sep, 18	11	-

- institutional shareholders have increased their position in CLRB stock as of 30 Jun 23 compared to 1 in the previous quarter (a -100.00% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 23	-	-
31 Mar, 23	-	-
30 Jun, 22	6	50.00%
31 Mar, 22	4	-33.33%
31 Dec, 21	6	20.00%
30 Sep, 21	5	-
30 Jun, 21	5	-16.67%
31 Mar, 21	6	200.00%
31 Dec, 20	2	-60.00%
30 Sep, 20	5	150.00%
30 Jun, 20	2	-33.33%
31 Mar, 20	3	-
31 Dec, 19	3	50.00%
30 Sep, 19	2	100.00%
30 Jun, 19	1	-50.00%
31 Mar, 19	2	100.00%
31 Dec, 18	1	-
30 Sep, 18	-	-

- institutional shareholders have reduced their position in CLRB stock as of 30 Jun 23 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 23	1	-	5	-	-	-	-	-100.00%	-	-
31 Mar, 23	1	-	5	-	-	-	1	-	-	-
30 Jun, 22	28	-	6,561,180	-3.30%	107.38%	0.87%	9	28.57%	6	50.00%
31 Mar, 22	28	-17.65%	6,784,960	4.28%	111.04%	0.81%	7	-46.15%	4	-33.33%
31 Dec, 21	34	-2.86%	6,506,789	-10.71%	117.21%	0.79%	13	-23.53%	6	20.00%
30 Sep, 21	35	-14.63%	7,287,078	-41.51%	121.72%	0.22%	17	-34.62%	5	-
30 Jun, 21	41	-2.38%	12,459,505	-17.09%	236.14%	0.24%	26	-3.70%	5	-16.67%
31 Mar, 21	42	13.51%	15,027,195	-14.93%	312.16%	0.23%	27	-10.00%	6	200.00%
31 Dec, 20	37	94.74%	17,664,507	411.64%	366.95%	2.13%	30	233.33%	2	-60.00%
30 Sep, 20	19	-9.52%	3,452,550	20.44%	131.14%	0.30%	9	-30.77%	5	150.00%
30 Jun, 20	21	50.00%	2,866,552	103.24%	207.82%	0.92%	13	116.67%	2	-33.33%
31 Mar, 20	14	40.00%	1,410,400	8.70%	150.21%	0.79%	6	50.00%	3	-
31 Dec, 19	10	-9.09%	1,297,481	-13.85%	138.18%	0.54%	4	-20.00%	3	50.00%
30 Sep, 19	11	22.22%	1,506,142	-19.87%	160.45%	0.22%	5	25.00%	2	100.00%
30 Jun, 19	9	12.50%	1,879,701	661.36%	269.94%	10.09%	4	300.00%	1	-50.00%
31 Mar, 19	8	-11.11%	246,887	-6.03%	51.72%	0.66%	1	-75.00%	2	100.00%
31 Dec, 18	9	-18.18%	262,722	-51.50%	88.70%	0.31%	4	-63.64%	1	-
30 Sep, 18	11	-	541,706	-	170.09%	-	11	-	-	-

Cellectar Biosciences Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Mar 16, 2023	Shustov Andrei	officer	Senior Vice President, Medical		Sell	-	-	-	7,181

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Dec 12, 2023	Lea Darrell Shane	officer	Chief Commercial Officer	A-Award	Buy	100,000	$1.68	$168.00K	100,000
Dec 12, 2023	Lea Darrell Shane	officer	Chief Commercial Officer	A-Award	Buy	39,599	-	-	39,599
Dec 12, 2023	Kolean Chad J	officer	Chief Financial Officer	A-Award	Buy	104,000	$1.68	$174.72K	104,000
Dec 12, 2023	Kolean Chad J	officer	Chief Financial Officer	A-Award	Buy	42,554	-	-	42,578
Dec 12, 2023	Shustov Andrei	officer	Senior Vice President, Medical	A-Award	Buy	47,856	-	-	55,037
Dec 12, 2023	Longcor Jarrod	officer	Chief Operating Officer	A-Award	Buy	144,000	$1.68	$241.92K	144,000
Dec 12, 2023	Longcor Jarrod	officer	Chief Operating Officer	A-Award	Buy	42,927	-	-	53,141
Dec 12, 2023	CARUSO JAMES V	director, officer	President and CEO	A-Award	Buy	261,000	$1.68	$438.48K	261,000
Dec 12, 2023	CARUSO JAMES V	director, officer	President and CEO	A-Award	Buy	40,596	-	-	49,236
Jun 28, 2023	Swirsky Douglas J	director	-	A-Award	Buy	37,500	$1.85	$69.38K	71,925
Jun 28, 2023	NEIS JOHN	director	-	A-Award	Buy	25,000	$1.85	$46.25K	47,887
Jun 28, 2023	Loren Stefan	director	-	A-Award	Buy	25,000	$1.85	$46.25K	47,885
Jun 28, 2023	DRISCOLL FREDERICK W	director	-	A-Award	Buy	25,000	$1.85	$46.25K	47,650
Jun 28, 2023	Chanan-Khan Asher	director	-	A-Award	Buy	25,000	$1.85	$46.25K	40,600
Mar 16, 2023	Shustov Andrei	officer	Senior Vice President, Medical	A-Award	Buy	100,000	$1.67	$167.00K	100,000
Mar 16, 2023	Shustov Andrei	officer	Senior Vice President, Medical		Sell	-	-	-	7,181
Jan 18, 2023	Longcor Jarrod	officer	Chief Operating Officer	A-Award	Buy	144,000	-	-	144,000
Jan 18, 2023	CARUSO JAMES V	officer	President and CEO	A-Award	Buy	261,000	-	-	261,000
Jan 18, 2023	Kolean Chad J	officer	Chief Financial Officer	A-Award	Buy	104,000	-	-	104,000
Dec 15, 2022	Lea Darrell Shane	director	Chief Commercial Officer	A-Award	Buy	100,000	-	-	100,000

The last insider sell of Cellectar Biosciences's stock was made by Shustov Andrei on Mar 16 2023, selling - shares at - per share (valued at -).

Cellectar Biosciences Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2023	5	-	-
Q1 2023	4	1	400.00%
Q4 2022	1	-	-
Q2 2022	5	-	-
Q1 2022	4	1	400.00%
Q3 2021	2	-	-
Q2 2021	5	-	-
Q1 2021	6	5	120.00%
Q4 2020	3	-	-
Q3 2020	1	1	100.00%
Q2 2020	12	-	-
Q1 2020	7	-	-
Q3 2019	1	-	-
Q2 2019	5	-	-
Q1 2019	4	-	-
Q4 2018	12	2	600.00%
Q3 2018	1	-	-
Q2 2018	1	-	-
Q1 2018	-	2	-
Q4 2017	-	1	-

5 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Cellectar Biosciences's insiders, as of Q2 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2023	-	-	-
Q1 2023	-	-	-
Q4 2022	-	-	-
Q2 2022	-	-	-
Q1 2022	-	-	-
Q3 2021	2	-	-
Q2 2021	-	-	-
Q1 2021	1	6	16.67%
Q4 2020	3	-	-
Q3 2020	-	-	-
Q2 2020	7	-	-
Q1 2020	-	-	-
Q3 2019	-	-	-
Q2 2019	-	-	-
Q1 2019	1	-	-
Q4 2018	1	4	25.00%
Q3 2018	1	-	-
Q2 2018	-	-	-
Q1 2018	-	2	-
Q4 2017	-	1	-

As of Q2 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Cellectar Biosciences's stocks.

Cellectar Biosciences Peer Ownership

Ticker	Company
CAPR	Capricor Therapeutics, Inc.
ALRN	Aileron Therapeutics, Inc.
NXTC	NextCure, Inc.
TENX	Tenax Therapeutics, Inc.
DFFN	CervoMed Inc.
BPTH	Bio-Path Holdings, Inc.
MNPR	Monopar Therapeutics Inc.
PULM	Pulmatrix, Inc.
LBPH	Longboard Pharmaceuticals, Inc.
BOLT	Bolt Biotherapeutics, Inc.
CBIO	Gyre Therapeutics, Inc.
BNTC	Benitec Biopharma Inc.
LUMO	Lumos Pharma, Inc.

CLRB Ownership FAQ

Who Owns Cellectar Biosciences?

Cellectar Biosciences is owned by institutional shareholders (0%), insiders (3.20%), and public (0%). The largest institutional shareholder of Cellectar Biosciences is MENDOTA FINANCIAL GROUP, LLC (0% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.01% of total shares).

Who are the major institutional shareholders of Cellectar Biosciences?

Cellectar Biosciences's major institutional shareholders are MENDOTA FINANCIAL GROUP, LLC. The top five shareholders own together 0% of the company's share outstanding.

How many Cellectar Biosciences shareholders are there?

As of Jun 2023, there are 1 institutional shareholders of Cellectar Biosciences.

What percentage of Cellectar Biosciences is owned by MENDOTA FINANCIAL GROUP, LLC?

MENDOTA FINANCIAL GROUP, LLC owns 0 shares of Cellectar Biosciences, representing 0% of the company's total shares outstanding, valued at $0 (as of Sep 2023).